{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_relationships_comments in Relationship Comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
NCT03906539: Phase 4 Interventional Completed Dyslipidemias
(2019)
Source URL:
First approved in 2011
Source:
21 CFR 333B
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 358H
(2008)
Source URL:
First approved in 2008
Source:
21 CFR 358H
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M021
(2023)
Source URL:
First approved in 1996
Source:
Cranberry Relief by The Garmon Corporation
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
G1 SPECIFIED SUBSTANCE
Status:
Investigational
Source:
INN:deulumateperone [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
INN:enozertinib [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02310464: Phase 1 Interventional Completed Metastatic Gastric Cancer
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02848248: Phase 1 Interventional Terminated Acute Myeloid Leukemia
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00606645: Phase 1 Interventional Completed Hodgkin Lymphoma
(2007)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03993106: Phase 2 Interventional Recruiting Kaposi Sarcoma
(2020)
Source URL:
Class:
CONCEPT